Holen Sie sich die Stockscreener-App
0.6518
2.72%
-0.0182
Vorhandelsmarkt:
.65
-0.0018
-0.28%
Schlusskurs vom Vortag:
$0.67
Offen:
$0.69
24-Stunden-Volumen:
635.94K
Relative Volume:
0.75
Marktkapitalisierung:
$30.75M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.08M
KGV:
-0.7604
EPS:
-0.8572
Netto-Cashflow:
$-14.75M
1W Leistung:
-3.79%
1M Leistung:
-2.82%
6M Leistung:
-40.75%
1J Leistung:
-46.57%
1-Tages-Spanne:
$0.6517
$0.70
1-Wochen-Bereich:
$0.6431
$0.70
52-Wochen-Spanne:
$0.6108
$3.02
Iterum Therapeutics Plc Stock (ITRM) Company Profile
Firmenname
Iterum Therapeutics Plc
Sektor
Branche
Telefon
(872) 225-6077
Adresse
3 DUBLIN LANDINGS, DUBLIN 1
Vergleichen Sie ITRM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ITRM
Iterum Therapeutics Plc
|
0.6518 | 32.19M | 0 | -24.08M | -14.75M | -0.8572 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-28 | Hochstufung | Gabelli & Co | Sell → Hold |
| 2021-03-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-06-02 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-01-21 | Herabstufung | Gabelli & Co | Buy → Sell |
| 2019-12-11 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Iterum Therapeutics Plc Aktie (ITRM) Neueste Nachrichten
Will Iterum Therapeutics plc stock split attract more investorsJuly 2025 Summary & Safe Capital Preservation Plans - newser.com
Visual analytics tools that track Iterum Therapeutics plc performanceQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
Is Iterum Therapeutics plc stock vulnerable to regulatory risksDividend Hike & Weekly Breakout Watchlists - newser.com
Visualizing Iterum Therapeutics plc stock with heatmaps2025 Support & Resistance & Daily Profit Focused Stock Screening - newser.com
Can Iterum Therapeutics plc stock sustain market leadershipTake Profit & Real-Time Chart Pattern Alerts - newser.com
Sentiment analysis tools applied to Iterum Therapeutics plcJuly 2025 Momentum & Technical Pattern Based Signals - newser.com
Using portfolio simulators with Iterum Therapeutics plc includedWeekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com
What to expect from Iterum Therapeutics plc in the next 30 daysGlobal Markets & Low Risk Growth Stock Ideas - newser.com
Reversal indicators forming on Iterum Therapeutics plc stock2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - newser.com
Will Iterum Therapeutics plc see short term momentumWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Combining machine learning predictions for Iterum Therapeutics plcProfit Target & Risk Controlled Stock Alerts - newser.com
Why Iterum Therapeutics plc stock appeals to analystsEarnings Miss & Smart Money Movement Tracker - newser.com
Published on: 2025-10-29 21:40:27 - newser.com
Published on: 2025-10-28 17:51:32 - fcp.pa.gov.br
Is Iterum Therapeutics plc stock a safe buy before earningsJuly 2025 Levels & Capital Protection Trading Alerts - fcp.pa.gov.br
How Iterum Therapeutics plc stock performs after earnings2025 Volume Leaders & Daily Risk Controlled Trade Plans - newser.com
Finanzdaten der Iterum Therapeutics Plc-Aktie (ITRM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):